153 related articles for article (PubMed ID: 7826901)
1. Immunoconjugates: lessons from animal models.
Canevari S; Colombatti M; Colnaghi MI
Ann Oncol; 1994 Oct; 5(8):698-701. PubMed ID: 7826901
[TBL] [Abstract][Full Text] [Related]
2. Immunoconjugates and immunotoxins for therapy of solid tumors.
Hellström I; Trail P; Siegall C; Firestone R; Hellström KE
Cancer Chemother Pharmacol; 1996; 38 Suppl():S35-6. PubMed ID: 8765413
[No Abstract] [Full Text] [Related]
3. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.
Stan AC; Radu DL; Casares S; Bona CA; Brumeanu TD
Cancer Res; 1999 Jan; 59(1):115-21. PubMed ID: 9892195
[TBL] [Abstract][Full Text] [Related]
4. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates.
Trail PA; Willner D; Lasch SJ; Henderson AJ; Hofstead S; Casazza AM; Firestone RA; Hellström I; Hellström KE
Science; 1993 Jul; 261(5118):212-5. PubMed ID: 8327892
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging.
Panousis C; Pietersz GA
Drugs Aging; 1999 Jul; 15(1):1-13. PubMed ID: 10459728
[TBL] [Abstract][Full Text] [Related]
6. Drug immunotargeting for carcinomas: a reality at last?
Casazza AM; Trail PA; Hellström KE
Ann Oncol; 1994 Oct; 5(8):703-8. PubMed ID: 7826902
[No Abstract] [Full Text] [Related]
7. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Jackson D; Gooya J; Mao S; Kinneer K; Xu L; Camara M; Fazenbaker C; Fleming R; Swamynathan S; Meyer D; Senter PD; Gao C; Wu H; Kinch M; Coats S; Kiener PA; Tice DA
Cancer Res; 2008 Nov; 68(22):9367-74. PubMed ID: 19010911
[TBL] [Abstract][Full Text] [Related]
8. Antibody-targeted drugs for the therapy of cancer.
Pietersz GA; Krauer K
J Drug Target; 1994; 2(3):183-215. PubMed ID: 7812691
[TBL] [Abstract][Full Text] [Related]
9. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
Dillman RO; Johnson DE; Ogden J; Beidler D
Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
Gupta B; Torchilin VP
Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.
Halin C; Niesner U; Villani ME; Zardi L; Neri D
Int J Cancer; 2002 Nov; 102(2):109-16. PubMed ID: 12385005
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
14. Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus.
Kinch MS; Kraft Z; Schwartz T
Drug Discov Today; 2023 Mar; 28(3):103462. PubMed ID: 36464142
[TBL] [Abstract][Full Text] [Related]
15. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
Takahashi H; Adachi K; Yamaguchi F; Teramoto A
Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
[TBL] [Abstract][Full Text] [Related]
16. Trial of targeting therapy against malignant glioma using monoclonal antibody.
Takahashi H; Teramoto A
J Nippon Med Sch; 2004 Feb; 71(1):2-3. PubMed ID: 15129587
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in cancer therapy.
Oldham RK
J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.
Sharkey RM; Goldenberg DM
CA Cancer J Clin; 2006; 56(4):226-43. PubMed ID: 16870998
[TBL] [Abstract][Full Text] [Related]
19. Integration of monoclonal antibodies and immunoconjugates into the treatment of acute myeloid leukemia.
Amadori S; Stasi R
Curr Opin Hematol; 2008 Mar; 15(2):95-100. PubMed ID: 18300754
[TBL] [Abstract][Full Text] [Related]
20. Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells.
Goldmacher VS; Kovtun YV
Ther Deliv; 2011 Mar; 2(3):397-416. PubMed ID: 22834009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
